139 related articles for article (PubMed ID: 2445294)
21. [Clinical studies of gamma-seminoprotein in prostatic disease. I. Clinical evaluation of serum gamma-seminoprotein].
Hasegawa S; Nakashima J; Nakashima Y; Nakamura S; Kimura S
Hinyokika Kiyo; 1987 Dec; 33(12):2055-8. PubMed ID: 3329453
[TBL] [Abstract][Full Text] [Related]
22. Advances in biological markers for cancer.
Klavins JV
Ann Clin Lab Sci; 1983; 13(4):275-80. PubMed ID: 6194735
[TBL] [Abstract][Full Text] [Related]
23. [Tumor markers in testicular tumors].
Jibiki K; Odagiri E; Demura R; Demura H; Yamaguchi Y
Gan No Rinsho; 1985 Oct; 31(13):1709-16. PubMed ID: 3841165
[TBL] [Abstract][Full Text] [Related]
24. [A case of alpha-fetoprotein, carcinoembryonic antigen and human chorionic gonadotropin producing renal cell carcinoma].
Takakura N; Mimura H; Hamazaki K; Kim H; Hirata K; Miwata H; Kimura T; Sakata T; Hosoba T; Orita K
Gan No Rinsho; 1987 Sep; 33(11):1385-90. PubMed ID: 2444728
[TBL] [Abstract][Full Text] [Related]
25. Tumor markers in testis cancer.
Klein EA
Urol Clin North Am; 1993 Feb; 20(1):67-73. PubMed ID: 7679533
[TBL] [Abstract][Full Text] [Related]
26. Biological markers of human tumors and monitoring of cancer treatment.
Tanneberger S; Nissen E; Ziegenbein R
Arch Geschwulstforsch; 1979; 49(6):528-34. PubMed ID: 94534
[TBL] [Abstract][Full Text] [Related]
27. [Recent advancement of the treatment of urological malignancies].
Akaza H
Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():157-64. PubMed ID: 10410670
[TBL] [Abstract][Full Text] [Related]
28. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
Kobayashi T; Kawakita M; Terachi T; Habuchi T; Ogawa O; Kamoto T
J Surg Oncol; 2006 Dec; 94(7):619-23. PubMed ID: 17111392
[TBL] [Abstract][Full Text] [Related]
29. [Urogenital cancer].
Koiso K; Rinsho K; Nemoto R; Ishikawa H; Ohtani M; Uchida K; Noguchi R
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):971-7. PubMed ID: 2658819
[TBL] [Abstract][Full Text] [Related]
30. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
Akimoto S; Ohki T; Ichikawa T; Akakura K; Shimazaki J
Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
[TBL] [Abstract][Full Text] [Related]
31. The utility of microscopic findings and immunohistochemistry in the classification of necrotic testicular tumors: a study of 11 cases.
Miller JS; Lee TK; Epstein JI; Ulbright TM
Am J Surg Pathol; 2009 Sep; 33(9):1293-8. PubMed ID: 19461507
[TBL] [Abstract][Full Text] [Related]
32. [Clinical evaluation of six tumor markers (ferritin, CEA, TPA, AFP, PAP, gamma-Sm) in serum in patients with urogenital malignancies].
Koizumi F; Nakamura E; Kawamura T; Ishimori A; Hoshi S; Matsuda S
Rinsho Byori; 1986 Sep; 34(9):1053-8. PubMed ID: 2432295
[No Abstract] [Full Text] [Related]
33. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.
Beck SD; Patel MI; Sheinfeld J
J Urol; 2004 Jan; 171(1):168-71. PubMed ID: 14665869
[TBL] [Abstract][Full Text] [Related]
34. Two prostate-specific antigens, gamma-seminoprotein and beta-microseminoprotein.
Hara M; Kimura H
J Lab Clin Med; 1989 May; 113(5):541-8. PubMed ID: 2654306
[TBL] [Abstract][Full Text] [Related]
35. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
[TBL] [Abstract][Full Text] [Related]
36. [Clinical evaluation of gamma-seminoprotein as a serum marker of prostate carcinoma].
Sugimura Y; Sakurai M; Hioki T; Hayashi N; Yamakawa K; Tajima K; Tochigi H; Kawamura J
Hinyokika Kiyo; 1988 Dec; 34(12):2129-34. PubMed ID: 2467541
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
[TBL] [Abstract][Full Text] [Related]
38. Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors.
Arita N; Ushio Y; Hayakawa T; Uozumi T; Watanabe M; Mori T; Mogami H
Oncodev Biol Med; 1980; 1(4-5):235-40. PubMed ID: 6169060
[TBL] [Abstract][Full Text] [Related]
39. [Tumor markers in urological malignancies].
Kuriyama M
Nihon Rinsho; 1996 Jun; 54(6):1631-6. PubMed ID: 8691621
[TBL] [Abstract][Full Text] [Related]
40. Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer.
Ogawa A; Yoshida A; Kanda T; Sugihara S; Suzuki T; Tamura J; Kobayashi I; Nakazato Y
J Med; 2000; 31(1-2):101-10. PubMed ID: 10998759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
